Gilternib 40mg (Gilteritinib)

Description

Gilternib 40mg is a targeted medication used for the treatment of acute myeloid leukemia (AML) with a specific genetic mutation called FLT3. It is a tyrosine kinase inhibitor that works by blocking the activity of the FLT3 protein, which is responsible for the growth and division of cancer cells. Taken orally in tablet form, Gilternib is typically prescribed for patients who have relapsed or are refractory to initial chemotherapy treatments. While it offers a new treatment option for FLT3-mutated AML, it may have potential side effects such as nausea, diarrhea, fatigue, and liver function abnormalities. Close monitoring and adherence to healthcare providers’ instructions are crucial for safe and effective use of Gilternib 40mg.

About Gilternib 40mg

Gilternib 40mg is a medication used in the treatment of acute myeloid leukemia (AML) with a specific genetic mutation called FLT3. It is classified as a tyrosine kinase inhibitor, which means it works by blocking the activity of the FLT3 protein that is responsible for the growth and division of cancer cells.

As a targeted therapy, Gilternib specifically targets cells with the FLT3 mutation, making it an effective treatment option for patients with this particular form of AML. It is typically prescribed for patients who have relapsed or are refractory to initial chemotherapy treatments.

Gilternib is available in tablet form and is taken orally at a dose of 40mg once daily. Like any medication, it may cause side effects such as nausea, diarrhea, fatigue, and liver function abnormalities. It is important for patients to closely follow their healthcare provider’s instructions and report any concerning side effects.

Gilternib 40mg represents a significant advancement in the treatment of FLT3-mutated AML, offering patients a targeted therapy option that can help to slow down the progression of their disease and improve overall outcomes.

Side Effects

1. Nausea: Some patients may experience feelings of sickness or queasiness.
2. Diarrhea: Gilternib can cause loose or watery bowel movements.
3. Fatigue: Patients may feel tired, weak, or lacking in energy.
4. Liver function abnormalities: Gilternib may cause changes in liver enzyme levels as observed in liver function tests.
5. Muscle or joint pain: Some individuals may experience discomfort or achiness in their muscles or joints.
6. Headache: Gilternib may lead to mild to moderate headaches.
7. Edema: Swelling or fluid retention, particularly in the hands, feet, or legs, may occur.
8. Respiratory infections: Gilternib can potentially increase the risk of developing respiratory infections, such as pneumonia or bronchitis.

Storage 

Store Gilternib 40mg medicine at room temperature (20-25°C/68-77°F) in its original packaging. Keep it away from moisture, direct light, heat sources, and freezing. Adhere to the labeled instructions and consult a healthcare professional for specific storage guidelines.Keep out of children’s reach.

Dosages 

• The recommended dosage of Gilternib 40mg is typically 120mg (three tablets of 40mg) taken orally once daily.
• The tablets should be swallowed whole with water and can be taken with or without food.
• It is important to follow the specific instructions provided by your healthcare professional regarding the dosage and duration of treatment.
• Dosage adjustments or modifications may be made based on individual response, tolerability, and the presence of any underlying medical conditions.
• It is crucial to adhere to the prescribed dosage schedule and not exceed the recommended amount.
• If you miss a dose, consult with your healthcare professional for guidance on how to proceed.
• Always consult with your healthcare professional for personalized dosing instructions and to ensure the appropriate use of Gilternib 40mg medicine for your specific condition.